MedPath

Galderma Group AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
$22.9B
Website
http://www.galderma.com/

A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study of Restylane Skinboosters Vital Lidocaine

Not Applicable
Not yet recruiting
Conditions
Skin Quality Improvement
First Posted Date
2025-07-02
Last Posted Date
2025-07-02
Lead Sponsor
Galderma R&D
Target Recruit Count
171
Registration Number
NCT07047638

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Not Applicable
Not yet recruiting
Conditions
Systemic Sclerosis
First Posted Date
2025-07-02
Last Posted Date
2025-07-02
Lead Sponsor
Galderma R&D
Target Recruit Count
162
Registration Number
NCT07047690

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

Not yet recruiting
Conditions
Prurigo Nodularis
First Posted Date
2025-05-25
Last Posted Date
2025-06-10
Lead Sponsor
Galderma R&D
Target Recruit Count
600
Registration Number
NCT06988618

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

Not yet recruiting
Conditions
Atopic Dermatitis
First Posted Date
2025-05-25
Last Posted Date
2025-07-03
Lead Sponsor
Galderma R&D
Target Recruit Count
1000
Registration Number
NCT06988605
Locations
🇺🇸

Galderma Investigational Site 7061, Castle Rock, Colorado, United States

🇺🇸

Galderma Investigational Site 7059, Fairfield, Connecticut, United States

🇺🇸

Galderma Investigational Site 7063, Cutler Bay, Florida, United States

and more 6 locations

Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple Hollowing

Not Applicable
Recruiting
Conditions
Temple Hollowing
First Posted Date
2024-10-30
Last Posted Date
2025-01-17
Lead Sponsor
Galderma R&D
Target Recruit Count
162
Registration Number
NCT06665477
Locations
🇨🇳

Galderma Investigational Site #6340, Beijing, Beijing, China

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

Not Applicable
Completed
Conditions
Chin Augmentation
Interventions
Device: Restylane Shaype
Device: Restylane Defyne
Device: Restylane Lyft lidocaine
First Posted Date
2024-05-24
Last Posted Date
2025-01-31
Lead Sponsor
Galderma R&D
Target Recruit Count
45
Registration Number
NCT06428214
Locations
🇨🇦

Galderma Investigational Site # 8754, Vancouver, British Columbia, Canada

🇨🇦

Galderma Investigational Site 8379, Burlington, Ontario, Canada

🇨🇦

Galderma Investigational Site 8690, Westmount, Quebec, Canada

Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand

Not Applicable
Completed
Conditions
Skin Aging of Dorsal Hands
Interventions
Device: Restylane Skinboosters Vital Lidocaine
Device: Restylane Vital
First Posted Date
2024-04-18
Last Posted Date
2025-02-19
Lead Sponsor
Galderma R&D
Target Recruit Count
90
Registration Number
NCT06372782
Locations
🇨🇳

Galderma Research Site 01, Shanghai, Shanghai, China

🇨🇳

Galderma Research Site 02, Hangzhou, Zhejiang, China

🇨🇳

Galderma Research Site 03, Hangzhou, Zhejiang, China

A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis Patients

Phase 4
Completed
Conditions
Psoriasis
Plaque Psoriasis
Interventions
Drug: Cetaphil
First Posted Date
2024-04-10
Last Posted Date
2024-10-24
Lead Sponsor
Galderma R&D
Target Recruit Count
46
Registration Number
NCT06357221
Locations
🇺🇸

Southeast Dermatology Specialists, LLC, Douglasville, Georgia, United States

🇺🇸

Dermatology Consulting Services, High Point, North Carolina, United States

Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies

Not Applicable
Active, not recruiting
Conditions
Skin Laxity
Weight Loss
Photoaging
Photodamaged Skin
Volume Deficiency of the Midface
Interventions
Device: Sculptra treatment
Device: Restylane Treatment
First Posted Date
2024-04-08
Last Posted Date
2024-12-13
Lead Sponsor
Galderma R&D
Target Recruit Count
40
Registration Number
NCT06351358
Locations
🇺🇸

Somenek + Pittman MD: Advanced Plastic Surgery, Washington, District of Columbia, United States

🇺🇸

Lorenc Aesthetic Plastic Surgery Center, New York, New York, United States

A Comparative Analysis of Two Hyaluronic Acid Fillers for Nasolabial Fold Correction

Not Applicable
Active, not recruiting
Conditions
Wrinkle
Interventions
Device: RHA3 Treatment in Nasolabial Fold
Device: Defyne Treatment in Nasolabial Fold
First Posted Date
2024-04-08
Last Posted Date
2024-10-24
Lead Sponsor
Galderma R&D
Target Recruit Count
15
Registration Number
NCT06351293
Locations
🇺🇸

The Aesthetic Clinique, Santa Rosa Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath